Brexit and what it means for access to medicines
The UK’s 2019 exit from the European Union looms, and as the prospect of a ‘No Deal’ Brexit approaches, new challenges abound. One obstacle facing the national healthcare provider - and patients in both the UK and EU - is a potentially disrupted supply of medicines.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.